Form 4 for IDXX Idexx Laboratories
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-01 · accession 0000874716-25-000102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-03 | 2025-06-01 | IDXX | Johnson Michael Perkins | EVP | F - Tax | $513.36 | -1,499 | 2,365 | -39% | -$769.5K |
| D | 2025-06-03 | 2025-06-01 | IDXX | Johnson Michael Perkins | EVP | M - OptEx | $0.00 | +3,382 | 3,864 | +701% | $0 |
| D | 2025-06-03 | 2025-06-01 | IDXX | Johnson Michael Perkins | EVP | M - OptEx | — | -3,382 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-01 | F | D | 1,499 | $513.36 | 2,365.34 | D | — | — | (F2) Closing price of Issuer common stock on the Nasdaq market on May 30, 2025. |
| 2 | Common | Common Stock | 2025-06-01 | M | A | 3,382 | $0.00 | 3,864.34 | D | — | — | (F1) Includes 15 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025. |
| 3 | Derivative | Restricted Stock Unit | 2025-06-01 | M | D | 3,382 | — | 0 | D | — · — to — | 3,382 Common Stock | (F4) Not applicable. (F3) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock and vested in one installment on June 1, 2025. |